Refine
Year of publication
Document Type
- Article (46)
- Conference Proceeding (10)
Has Fulltext
- yes (56)
Is part of the Bibliography
- no (56)
Keywords
- Hemorrhage (4)
- meningioma (3)
- Death rates (2)
- Lesions (2)
- Multivariate analysis (2)
- Neurology (2)
- Prognosis (2)
- Pulmonary embolism (2)
- Quality of life (2)
- Subarachnoid hemorrhage (2)
- dexamethasone (2)
- dysphagia (2)
- glioblastoma (2)
- glioma (2)
- AVM hemorrhage (1)
- Acute-on-chronic subdural hematoma (1)
- Aneurysm (1)
- Aneurysms (1)
- Angiography (1)
- Anticoagulant therapy (1)
- Antiplatelet therapy (1)
- Apoptosis (1)
- Blood (1)
- Blood groups (1)
- Brain metastasis (1)
- Brain tumor surgery (1)
- Breast cancer (1)
- CMS (1)
- COVID-19 (1)
- Cancer treatment (1)
- Cerebral vasospasm (1)
- Computational model (1)
- Conservative treatment (1)
- Coronary heart disease (1)
- DBS (1)
- DNA damage (1)
- Deep brain stimulation (1)
- Diagnostic medicine (1)
- Direct oral anticoagulation (1)
- Ellipsoids (1)
- Epidural abscess (1)
- Epidural block (1)
- Epileptic seizures (1)
- Frontobasal (1)
- Glioblastoma (1)
- Glioblastoma survival (1)
- Glioma (1)
- HOD (1)
- Hardware erosion (1)
- Health care (1)
- Hedgehog (1)
- Hydrocephalus (1)
- Impulse generator (1)
- Infarction (1)
- KOOS IV (1)
- KPS (1)
- Left hemisphere (1)
- Linear regression analysis (1)
- Low-molecular-weight heparin (1)
- Magnetic resonance imaging (1)
- Malignant meningioma (1)
- Medical ethics (1)
- Medical research (1)
- Medical risk factors (1)
- Meningioma (1)
- Molecular signatures (1)
- Morbidity (1)
- Necrosis (1)
- Network model (1)
- Neuroimaging (1)
- Neuropilin (1)
- Non-aneurysmal (1)
- Non-perimesencephalic (1)
- Non-small cell lung cancer (1)
- Notch (1)
- Numerical simulation (1)
- Olfactory groove meningioma (1)
- Oncology (1)
- Outcome (1)
- Outcomes research (1)
- PEI (1)
- Parkinson’s disease (1)
- Perimesencephalic (1)
- Peritumoural oedema (1)
- Precision oncology (1)
- Prepontine (1)
- Prognostic biomarker (1)
- Pyogenic spondylodiscitis (1)
- Regression analysis (1)
- Resection (1)
- Return to work (1)
- Risk factor (1)
- SAH (1)
- SAH close (1)
- SF-36 (1)
- SKALE score (1)
- STAMPE2 (1)
- STAT3 (1)
- Scalp defect (1)
- Seizure (1)
- Signs and symptoms (1)
- Skull base (1)
- Status epilepticus (1)
- Stereotactic radiosurgery (1)
- Surgery (1)
- Systems biology (1)
- Systems medicine (1)
- TTFields (1)
- Therapeutic anticoagulation (1)
- Tissue expander (1)
- Toxicity (1)
- VEGF (1)
- VEGF receptors (1)
- VIM (1)
- Volumetric analysis (1)
- anaemia (1)
- aneurysm (1)
- anticonvulsants (1)
- aspiration (1)
- blood culture (1)
- brain cancer (1)
- brain infection (1)
- brain shift (1)
- brain tumor (1)
- cancer stem cells (1)
- carpal tunnel syndrome (1)
- cerebellar mutism (1)
- cerebellum (1)
- cerebral imaging (1)
- cerebral vasospasm (CVS) (1)
- clinical outcome (1)
- corticosteroids (1)
- delayed cerebral ischemia (DCI) (1)
- elderly (1)
- epilepsy (1)
- essential tremor (1)
- facial nerve functional outcome (1)
- functional outcome (1)
- glioma microenvironment (1)
- healthcare system (1)
- hearing nerve (1)
- immune infiltration (1)
- lipopolyplex (1)
- long-term outcome (1)
- medulloblastoma (1)
- microsurgical treatment (1)
- neurosurgery (1)
- neurysmal subarachnoid hemorrhage (aSAH) (1)
- non-aneurysmal (1)
- non-aneurysmal SAH (1)
- non-perimesencephalic (1)
- pandemic (1)
- perimesencephalic (1)
- peripheral nerve (1)
- peritumoral edema (1)
- peritumoral edema zone (1)
- polyethylenimine (1)
- posterior fossa tumor (1)
- predictor (1)
- prepontine (1)
- recovery (1)
- red blood cells (1)
- regenerative medicine (1)
- revision surgery (1)
- seizures (1)
- short-term (1)
- siRNA delivery (1)
- siRNA/RNAi (1)
- speech and language pathologist (1)
- spinal infection (1)
- statin treatment (1)
- stroke (1)
- subarachnoid hemorrhage (1)
- subdural hematoma (1)
- surgery (1)
- survival (1)
- swallowing (1)
- transfusion (1)
- translational investigation (1)
- translational study (1)
- ventralis intermedius nucleus (1)
- vestibular schwannoma (1)
Patient care in a neurointensive care unit (neuro-ICU) is challenging. Multidrug-resistant organisms (MDROs) are increasingly common in the routine clinical practice. We evaluated the impact of infection with MDROs on outcomes in patients with subarachnoid hemorrhage (SAH). A single-center retrospective analysis of SAH cases involving patients treated in the neuro-ICU was performed. The outcome was assessed 6 months after SAH using the modified Rankin Scale [mRS, favorable (0–2) and unfavorable (3–6)]. Data were compared by matched-pair analysis. Patient characteristics were well matched in the MDRO (n = 61) and control (n = 61) groups. In this center, one nurse was assigned to a two-bed room. If a MDRO was detected, the patient was isolated, and the nurse was assigned to the patient infected with the MDRO. In the MDRO group, 29 patients (48%) had a favorable outcome, while 25 patients (41%) in the control group had a favorable outcome; the difference was not significant (p > 0.05). Independent prognostic factors for unfavorable outcomes were worse status at admission (OR = 3.1), concomitant intracerebral hematoma (ICH) (OR = 3.7), and delayed cerebral ischemia (DCI) (OR = 6.8). Infection with MRDOs did not have a negative impact on the outcome in SAH patients. Slightly better outcomes were observed in SAH patients infected with MDROs, suggesting the benefit of individual care.
Background: Atypical intracerebral hemorrhage is a common form of primary manifestation of vascular malformations.
Objective: The aim of the present study is to determine clues to the cause of bleeding according to hemorrhage pattern (lobar, basal ganglia, infratentorial).
Methods: We retrospectively evaluated 343 consecutive neurosurgical patients with intracerebral hemorrhage (ICH), who were admitted to our neurosurgical department between 2006 and 2016. The study cohort includes only neurosurgical patients. Patients who underwent treatment by neurologists are not represented in this study. We assessed location of hemorrhage, hematoma volumes to rule out differences and predicitve variables for final outcome.
Results: In 171 cases (49.9%) vascular malformations, such as arteriovenous malformations (AVMs), cavernomas, dural fistulas and aneurysms were the cause of bleeding. 172 (50.1%) patients suffered from an intracerebral hemorrhage due to amyloid angiopathy or long standing hypertension. In patients with infratentorial hemorrhage a malformation was more frequently detected as in patients with supratentorial hemorrhage (36% vs. 16%, OR 2.9 [1.8;4.9], p<0.001). Among the malformations AVMs were most common (81%). Hematoma expansion was smaller in vascular malformation than non-malformation caused bleeding (24.1 cm3 vs. 64.8 cm3, OR 0.5 [0.4;0.7], p < 0.001,). In 6 (2.1%) cases diagnosis remained unclear. Final outcome was more favorable in patients with vascular malformations (63% vs. 12%, OR 12.8 [4.5;36.2], p<0.001).
Conclusion: Localization and bleeding patterns are predictive factors for origin of the hemorrhage. These predictive factors should quickly lead to appropriate vascular diagnostic measures. However, due to the inclusion criteria the validity of the study is limited and multicentre studies with further testing in general ICH patients are required.
Background: The prognostic factors and outcome of aneurysms appear to be dependent on its locations. Therefore, we compared left- and right- sided aneurysms in patients with aneurysmal subarachnoid hemorrhage (SAH) in terms of differences in outcome and prognostic factors.
Methods: Patients with SAH were entered into a prospectively collected database. A total of 509 patients with aneurysmal subarachnoid hemorrhage were retrospectively selected and stratified in two groups depending on side of ruptured aneurysm (right n = 284 vs. left n = 225). Midline aneurysms of the basilar and anterior communicating arteries were excluded from the analysis. Outcomes were assessed using the modified Rankin Scale (mRS; favorable (mRS 0–2) vs. unfavorable (mRS 3–6)) six months after SAH.
Results: We did not identify any differences in outcome depending on left- and right-sided ruptured aneurysms. In both groups, the significant negative predictive factors included clinical admission status (WFNS IV+V), Fisher 3- bleeding pattern in CT, the occurrence of delayed cerebral ischemia (DCI), early hydrocephalus and later shunt-dependence. The side of the ruptured aneurysm does not seem to influence patients´ outcome. Interestingly, the aneurysm side predicts the side of infarction, with a significant influence on patients´ outcome in case of left-sided infarctions. In addition, the in multivariate analysis side of aneurysm was an independent predictor for the side of cerebral infarctions.
Conclusion: The side of the ruptured aneurysms (right or left) did not influence patients’ outcome. However, the aneurysm-side predicts the side of delayed infarctions and outcome appear to be worse in patients with left-sided infarctions.
Objective: Cerebral vasospasm (CVS) after a ruptured arteriovenous malformation (AVM) is rarely reported. This study is aimed at evaluating the predictive variables in AVM hemorrhage for CVS. Methods: A total of 160 patients with ruptured AVMs were admitted to our neurosurgical department from 2002 to 2018. The frequency of cerebral vasospasm after AVM hemorrhage and the impact of AVM-associated aneurysms were evaluated. We compared different bleeding patterns, such as intracerebral hemorrhage (ICH), subarachnoid hemorrhage (SAH) or a combination of both (ICH + SAH) and evaluated predictive variables for outcome in last follow-up. Results: A total of 62 (39%) patients had AAA, mostly located prenidal (75.8%). AVMs with ruptured aneurysms often resulted in ICH with SAH component (p < 0.001). Eighty-two patients (51%) presented a SAH component, and CVS occurred in 6 patients (7.3%), mostly due to a ruptured infratentorial AVM (p < 0.03). Infratentorial location and the amount of SAH component (p < 0.001) predicted the incidence of CVS significantly. Cerebral infarction was significantly associated with CVS (p < 0.02). Conclusion: SAH component and infratentorial location of ruptured AVMs may harbor a higher risk for CVS. Follow-up with angiographic imaging should be considered in patients with infratentorial AVM hemorrhage and delayed neurologic deterioration to rule out CVS.
Background: The surgical treatment of giant olfactory groove meningiomas (OGMs) with marked perilesional brain oedema is still a surgical challenge. After tumour resection, increase of brain oedema may occur causing dramatic neurological deterioration and even death of the patient. The objective of this paper is to describe surgical features of a two-step staged resection of these tumours performed to counter increase of postoperative brain oedema.
Methods: This two-step staged resection procedure was carried out in a consecutive series of 19 patients harbouring giant OGMs. As first step, a bifrontal craniectomy was performed followed by a right-sided interhemispherical approach. About 80% of the tumour mass was resected leaving behind a shell-shaped tumour remnant. In the second step, carried out after the patients’ recovery from the first surgery and decline of oedema, the remaining part of the tumour was removed completely followed by duro- and cranioplasty.
Results: Ten patients recovered quickly from first surgery and the second operation was performed after a mean of 12.4 days. In eight patients, the second operation was carried out later between day 25 and 68 due to surgery-related complications, development of a trigeminal zoster, or to a persisting frontal brain oedema. Mean follow-up was 49.3 months and all but one patient had a good outcome regardless of surgery-related complications.
Conclusions: Our results suggest that a two-step staged resection of giant OGMs minimizes the increase of postoperative brain oedema as far as possible and translates into lower morbidity and mortality.
Short- and long-term effects of rehabilitation after perimesencephalic subarachnoid hemorrhage
(2021)
n about 25% of patients with spontaneous subarachnoid hemorrhage (SAH), a bleeding source cannot be identified during radiological diagnostics. Generally, the outcome of perimesencephalic or prepontine (PM) SAH is known to be significantly better than after non-PM SAH. Data about long-term follow-up concerning physical and mental health are scarce, so this study is reports on long-term results. We measured the influence of PM SAH on a quality-of-life modified Rankin (mRs) scale after six months. For long-term follow-up, a SF-36 questionnaire was used. Questionnaires were sent out between 18 and 168 months after ictus. In 37 patients, a long-term follow-up was available (up to 14 years after SAH). Data detected with the SF-36 questionnaire are compared to reference applicability to the standard population. In total, 37 patients were included for further analysis and divided in 2 subgroups; 13 patients (35%) received subsequent rehabilitation after clinical stay and 24 (65%) did not. In the short-term outcome, a significant improvement from discharge until follow-up was identified in patients with subsequent rehabilitation, but not in the matched pair group without rehabilitation. When PM SAH was compared to the standard population, a reduction in quality of life was identified in physical items (role limitations because of physical health problems, physical functioning) as well as in psychological items (role limitations because of emotional problems). Subsequent rehabilitation on PM SAH patients probably leads to an increase in independence and better mRs. While better mRs was shown at discharge in patients without subsequent rehabilitation, the mRs of rehabilitants was nearly identical after rehabilitation. Patients with good mRs also reached high levels of health-related quality of life (HRQoL) without rehabilitation. Thus, subsequent rehabilitation needs to be encouraged on an individual basis. Indication criteria for subsequent rehabilitation should be defined in further studies to improve patient treatment and efficiency in health care.